Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques. / Afzelius, Lovisa; Raubacher, Florian; Karlén, Anders; Jørgensen, Flemming Steen; Andersson, Tommy B; Masimirembwa, Collen M; Zamora, Ismael.

In: Drug Metabolism and Disposition, Vol. 32, No. 11, 2004, p. 1218-29.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Afzelius, L, Raubacher, F, Karlén, A, Jørgensen, FS, Andersson, TB, Masimirembwa, CM & Zamora, I 2004, 'Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques', Drug Metabolism and Disposition, vol. 32, no. 11, pp. 1218-29. https://doi.org/10.1124/dmd.32.11.

APA

Afzelius, L., Raubacher, F., Karlén, A., Jørgensen, F. S., Andersson, T. B., Masimirembwa, C. M., & Zamora, I. (2004). Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques. Drug Metabolism and Disposition, 32(11), 1218-29. https://doi.org/10.1124/dmd.32.11.

Vancouver

Afzelius L, Raubacher F, Karlén A, Jørgensen FS, Andersson TB, Masimirembwa CM et al. Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques. Drug Metabolism and Disposition. 2004;32(11):1218-29. https://doi.org/10.1124/dmd.32.11.

Author

Afzelius, Lovisa ; Raubacher, Florian ; Karlén, Anders ; Jørgensen, Flemming Steen ; Andersson, Tommy B ; Masimirembwa, Collen M ; Zamora, Ismael. / Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques. In: Drug Metabolism and Disposition. 2004 ; Vol. 32, No. 11. pp. 1218-29.

Bibtex

@article{ce1599f3b65343d9a0f3d3b2e2178c7e,
title = "Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques",
abstract = "This work had two separate aims: to evaluate different modeling techniques and to make a detailed structural characterization of CYP2C9. To achieve these goals, the consensus principal component analysis (CPCA) technique and distance measurements were used to explore available crystal structures, newly built homology models, and repeated molecular dynamics simulations. The CPCA was based on molecular interaction fields focused on the active site regions of the proteins and include detailed amino acid analysis. The comparison of the CYP2C9 and CYP2C5 crystal structures revealed differences in the flexible regions such as the B-C and F-G loop and the N and C termini. Cross homology models of CYP2C9 and CYP2C5, using their respective crystal structures as templates, indicated that such models were more similar to their templates than to their target proteins. Inclusion of multiple templates slightly improved the similarity to the crystal target in some cases and could be recommended even though it requires a careful manual alignment process. The application of molecular dynamics simulations to highly flexible proteins such as cytochromes P450 is also explored and the information is extracted by the CPCA. Advantages and drawbacks are presented for the different modeling techniques. Despite the varying modeling success, the models give insight and understanding by the mutual forming and discarding of hypotheses. This is a dynamic process since the crystal structures are improving with time and, therefore, the answers to the models are also changing accordingly.",
keywords = "Aryl Hydrocarbon Hydroxylases, Binding Sites, Cytochrome P-450 Enzyme System, Models, Molecular, Molecular Structure, Steroid 21-Hydroxylase",
author = "Lovisa Afzelius and Florian Raubacher and Anders Karl{\'e}n and J{\o}rgensen, {Flemming Steen} and Andersson, {Tommy B} and Masimirembwa, {Collen M} and Ismael Zamora",
note = "Copyright 2004 The American Society for Pharmacology and Experimental Therapeutics",
year = "2004",
doi = "10.1124/dmd.32.11.",
language = "English",
volume = "32",
pages = "1218--29",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "11",

}

RIS

TY - JOUR

T1 - Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques

AU - Afzelius, Lovisa

AU - Raubacher, Florian

AU - Karlén, Anders

AU - Jørgensen, Flemming Steen

AU - Andersson, Tommy B

AU - Masimirembwa, Collen M

AU - Zamora, Ismael

N1 - Copyright 2004 The American Society for Pharmacology and Experimental Therapeutics

PY - 2004

Y1 - 2004

N2 - This work had two separate aims: to evaluate different modeling techniques and to make a detailed structural characterization of CYP2C9. To achieve these goals, the consensus principal component analysis (CPCA) technique and distance measurements were used to explore available crystal structures, newly built homology models, and repeated molecular dynamics simulations. The CPCA was based on molecular interaction fields focused on the active site regions of the proteins and include detailed amino acid analysis. The comparison of the CYP2C9 and CYP2C5 crystal structures revealed differences in the flexible regions such as the B-C and F-G loop and the N and C termini. Cross homology models of CYP2C9 and CYP2C5, using their respective crystal structures as templates, indicated that such models were more similar to their templates than to their target proteins. Inclusion of multiple templates slightly improved the similarity to the crystal target in some cases and could be recommended even though it requires a careful manual alignment process. The application of molecular dynamics simulations to highly flexible proteins such as cytochromes P450 is also explored and the information is extracted by the CPCA. Advantages and drawbacks are presented for the different modeling techniques. Despite the varying modeling success, the models give insight and understanding by the mutual forming and discarding of hypotheses. This is a dynamic process since the crystal structures are improving with time and, therefore, the answers to the models are also changing accordingly.

AB - This work had two separate aims: to evaluate different modeling techniques and to make a detailed structural characterization of CYP2C9. To achieve these goals, the consensus principal component analysis (CPCA) technique and distance measurements were used to explore available crystal structures, newly built homology models, and repeated molecular dynamics simulations. The CPCA was based on molecular interaction fields focused on the active site regions of the proteins and include detailed amino acid analysis. The comparison of the CYP2C9 and CYP2C5 crystal structures revealed differences in the flexible regions such as the B-C and F-G loop and the N and C termini. Cross homology models of CYP2C9 and CYP2C5, using their respective crystal structures as templates, indicated that such models were more similar to their templates than to their target proteins. Inclusion of multiple templates slightly improved the similarity to the crystal target in some cases and could be recommended even though it requires a careful manual alignment process. The application of molecular dynamics simulations to highly flexible proteins such as cytochromes P450 is also explored and the information is extracted by the CPCA. Advantages and drawbacks are presented for the different modeling techniques. Despite the varying modeling success, the models give insight and understanding by the mutual forming and discarding of hypotheses. This is a dynamic process since the crystal structures are improving with time and, therefore, the answers to the models are also changing accordingly.

KW - Aryl Hydrocarbon Hydroxylases

KW - Binding Sites

KW - Cytochrome P-450 Enzyme System

KW - Models, Molecular

KW - Molecular Structure

KW - Steroid 21-Hydroxylase

U2 - 10.1124/dmd.32.11.

DO - 10.1124/dmd.32.11.

M3 - Journal article

C2 - 15483192

VL - 32

SP - 1218

EP - 1229

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 11

ER -

ID: 38393867